Our Clinical Trials

  • We research treatments and assessments for infection-associated chronic conditions.

  • We spent 2020-2022 conducting rapid and intensive research projects that helped us to better understand many of the underlying drivers of IACI symptoms. We now prioritize interventional trials that we believe have the best chance of treating or neutralizing those drivers. As new information becomes available it can affect how we prioritize research targets and interventional strategies.

  • You can send an email to The CoRE at Core@MountSinai.org